M G Law - JoVE Visualize

Showing results (31-40 of 75) with videos related to

Pageof 8

Sort By:

Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 1997

Prognosis of Kaposi's sarcoma as an initial and later AIDS associated illnessA Padiglione, D Goldstein, M G Law, et al.

Journal of Clinical Epidemiology|September 1, 1996

A comparison of patient interview data with pharmacy and medical records for patients with acquired immunodeficiency syndrome or human immunodeficiency virus infectionM G Law, S F Hurley, J B Carlin, et al.

HIV Medicine|February 20, 2007

Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatmentP Srasuebkul, C Ungsedhapand, K Ruxrungtham, et al.

AIDS (London, England)|April 24, 2001

Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination anti-retroviral therapyA E Grulich, Y Li, A M McDonald, et al.

Journal of Gastroenterology and Hepatology|June 26, 1998

Rising incidence of oesophageal adenocarcinoma in men in AustraliaR V Lord, M G Law, R L Ward, et al.

Cancer Research|January 15, 1994

Allelotype of human bladder cancerM A Knowles, P A Elder, M Williamson, et al.

Journal of Viral Hepatitis|May 16, 2014

Lower life expectancy among people with an HCV notification: a population-based linkage studyM Alavi, M G Law, J Grebely, et al.

Carcinogenesis|May 1, 1991

Susceptibility to phenobarbital promotion of hepatotumorigenesis: correlation with differential expression and induction of hepatic drug metabolizing enzymes in heavy and light male (C3H x VY) F1 hybrid miceG L Wolff, J E Leakey, J J Bazare, et al.

Epidemiology and Infection|May 19, 2006

Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug usersJ Amin, M G Law, J Micallef, et al.

HIV Medicine|February 26, 2015

Clinical and demographic factors associated with low viral load in early untreated HIV infection in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialM G Law, A Achhra, S G Deeks, et al.

Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:

Pageof 8

Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 1997

Prognosis of Kaposi's sarcoma as an initial and later AIDS associated illnessA Padiglione, D Goldstein, M G Law, et al.

Journal of Clinical Epidemiology|September 1, 1996

A comparison of patient interview data with pharmacy and medical records for patients with acquired immunodeficiency syndrome or human immunodeficiency virus infectionM G Law, S F Hurley, J B Carlin, et al.

HIV Medicine|February 20, 2007

Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatmentP Srasuebkul, C Ungsedhapand, K Ruxrungtham, et al.

AIDS (London, England)|April 24, 2001

Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination anti-retroviral therapyA E Grulich, Y Li, A M McDonald, et al.

Journal of Gastroenterology and Hepatology|June 26, 1998

Rising incidence of oesophageal adenocarcinoma in men in AustraliaR V Lord, M G Law, R L Ward, et al.

Cancer Research|January 15, 1994

Allelotype of human bladder cancerM A Knowles, P A Elder, M Williamson, et al.

Journal of Viral Hepatitis|May 16, 2014

Lower life expectancy among people with an HCV notification: a population-based linkage studyM Alavi, M G Law, J Grebely, et al.

Carcinogenesis|May 1, 1991

Susceptibility to phenobarbital promotion of hepatotumorigenesis: correlation with differential expression and induction of hepatic drug metabolizing enzymes in heavy and light male (C3H x VY) F1 hybrid miceG L Wolff, J E Leakey, J J Bazare, et al.

Epidemiology and Infection|May 19, 2006

Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug usersJ Amin, M G Law, J Micallef, et al.

HIV Medicine|February 26, 2015

Clinical and demographic factors associated with low viral load in early untreated HIV infection in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trialM G Law, A Achhra, S G Deeks, et al.

Pageof 8